Coherus BioSciences Announces New Employment Inducement Grants
December 22 2023 - 5:00PM
Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq:
CHRS), today announced that effective December 20, 2023, the
compensation committee of the Company’s board of directors granted
options to purchase an aggregate of 192,000 shares of the common
stock of the Company to five newly hired employees with a per share
exercise price of $1.94, the closing trading price on the grant
date. One Executive Vice President level executive was granted an
option to purchase 150,000 shares; and four additional non-officer
employees were granted options to purchase an aggregate of 42,000
shares.
The stock options were granted pursuant to the Coherus
BioSciences, Inc. 2016 Employment Commencement Incentive Plan,
which was approved by the Company’s board of directors in June 2016
under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity
grants to induce new employees to enter into employment with the
Company.
Coherus BioSciences Contact Information:
IR ContactJami Taylor, Head of Investor RelationsCoherus
BioSciences, Inc.IR@coherus.com
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jul 2023 to Jul 2024